Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry B Veprintsev

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Journal of the American Society for Mass Spectrometry|December 5, 2018
Insights into the Basal Activity and Activation Mechanism of the β1 Adrenergic Receptor Using Native Mass SpectrometryAgni F M Gavriilidou, Hanna Hunziker, Daniel Mayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2009
Structural evolution of p53, p63, and p73: implication for heterotetramer formationAndreas C Joerger, Sridharan Rajagopalan, Eviatar Natan, et al.
The EMBO Journal|February 15, 2011
Subunit-selective N-terminal domain associations organize the formation of AMPA receptor heteromersMaxim Rossmann, Madhav Sukumaran, Andrew C Penn, et al.
Structure (London, England : 1993)|April 20, 2005
Modulation of binding of DNA to the C-terminal domain of p53 by acetylationAssaf Friedler, Dmitry B Veprintsev, Stefan M V Freund, et al.
Molecules (Basel, Switzerland)|December 22, 2020
GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR SpectroscopyPhilip Rößler, Daniel Mayer, Ching-Ju Tsai, et al.
Protein Science : a Publication of the Protein Society|July 16, 2008
The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter siteMaria M García-Alai, Henning Tidow, Eviatar Natan, et al.
Plos One|November 9, 2013
AAscan, PCRdesign and MutantChecker: a suite of programs for primer design and sequence analysis for high-throughput scanning mutagenesisDawei Sun, Martin K Ostermaier, Franziska M Heydenreich, et al.
Pharmacology Research & Perspectives|June 28, 2022
Exploring the kinetic selectivity of drugs targeting the β<sub>1</sub> -adrenoceptorDavid A Sykes, Mireia Jiménez-Rosés, John Reilly, et al.
Molecular Cell|September 8, 2004
Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinaseBeatriz González, Michael J Schell, Andrew J Letcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
Targeted rescue of a destabilized mutant of p53 by an in silico screened drugFrank M Boeckler, Andreas C Joerger, Gaurav Jaggi, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Journal of the American Society for Mass Spectrometry|December 5, 2018
Insights into the Basal Activity and Activation Mechanism of the β1 Adrenergic Receptor Using Native Mass SpectrometryAgni F M Gavriilidou, Hanna Hunziker, Daniel Mayer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2009
Structural evolution of p53, p63, and p73: implication for heterotetramer formationAndreas C Joerger, Sridharan Rajagopalan, Eviatar Natan, et al.
The EMBO Journal|February 15, 2011
Subunit-selective N-terminal domain associations organize the formation of AMPA receptor heteromersMaxim Rossmann, Madhav Sukumaran, Andrew C Penn, et al.
Structure (London, England : 1993)|April 20, 2005
Modulation of binding of DNA to the C-terminal domain of p53 by acetylationAssaf Friedler, Dmitry B Veprintsev, Stefan M V Freund, et al.
Molecules (Basel, Switzerland)|December 22, 2020
GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR SpectroscopyPhilip Rößler, Daniel Mayer, Ching-Ju Tsai, et al.
Protein Science : a Publication of the Protein Society|July 16, 2008
The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter siteMaria M García-Alai, Henning Tidow, Eviatar Natan, et al.
Plos One|November 9, 2013
AAscan, PCRdesign and MutantChecker: a suite of programs for primer design and sequence analysis for high-throughput scanning mutagenesisDawei Sun, Martin K Ostermaier, Franziska M Heydenreich, et al.
Pharmacology Research & Perspectives|June 28, 2022
Exploring the kinetic selectivity of drugs targeting the β<sub>1</sub> -adrenoceptorDavid A Sykes, Mireia Jiménez-Rosés, John Reilly, et al.
Molecular Cell|September 8, 2004
Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinaseBeatriz González, Michael J Schell, Andrew J Letcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
Targeted rescue of a destabilized mutant of p53 by an in silico screened drugFrank M Boeckler, Andreas C Joerger, Gaurav Jaggi, et al.
Pageof 9